Table 2.
Baseline clinical characteristics of the survivor and the non-survivor groups
| Survivor (n = 73) | Non-survivor (n = 10) | P | |
|---|---|---|---|
| Gender (male, n%) | 39 (53.42) | 5 (50.00) | 1.000 |
| Gestational age (week) | 32.00 ± 1.71 | 31.17 ± 1.51 | 0.129 |
| Birth weight (g) | 1560.00 (1365.00–1925.00) | 1380.00 (1032.50–1477.50) | 0.013 |
| Age of onset (days) | 19.00 (12.50–24.50) | 12.50 (9.00–26.00) | 0.378 |
| SGA (n%) | 3 (30.00) | 18 (24.70) | 0.708 |
| Parenteral nutrition (n%) | 10 (100.00) | 57 (78.10) | 0.197 |
| Mechanical ventilation (n%) | 3 (30.00) | 7 (9.6) | 0.097 |
SGA, small for gestational age infants. Continuous variables of normal distribution were presented as mean ± SD, continuous variables of non-normal distribution were presented as medians (quartile ranges), and T-test or Mann–Whitney U-tests were applied to determine the group difference. Categorical variables were presented as absolute number and percentage and were compared using the T-test and Chi-square test, respectively. P < 0.05 was considered significant.